Industry News
Why are breast cancer survivors prone to weight gain?
7/15/2015
In a new study conducted by researchers from Johns Hopkins Kimmel Cancer Center, breast cancer survivors gained 3.6 lb more weight over 4 years compared with cancer-free women.
Researchers link low levels of pro-enkephalin to future breast cancer in healthy women
7/15/2015
sphingotec LLC announced today that the results of two studies examining the association between proenkephalin (pro-ENK) and incident breast cancer were published online in the Journal of Clinical...
Gene signature spots aggressive lung tumors
7/15/2015
New study shows that lung cancer tumors detected early with CT scans can be further classed into indolent and aggressive depending on their gene expression signature.
New classification system for brain tumors
7/15/2015
Doctors at Universitätsklinikum Erlangen have developed a simple radiological method to predict the development of gliomasDespite modern chemoradiation therapy it is still very difficult to give...
Nanospheres shield chemo drugs, safely release high doses in response to tumor secretions
7/15/2015
Scientists have designed nanoparticles that release drugs in the presence of a class of proteins that enable cancers to metastasize.
Dietary intervention primes triple-negative breast cancer for targeted therapy
7/15/2015
A diet that starves triple-negative breast cancer cells of an essential nutrient primes the cancer cells to be more easily killed by a targeted antibody treatment, UW Carbone Cancer Center scientists...
Anti-stress hormone may provide indication of breast cancer risk
7/15/2015
A new study from Lund University in Sweden shows that women with low levels of an anti-stress hormone have an increased risk of getting breast cancer.
The U.S. Food and Drug Administration has approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor specific types...
Noninvasive prenatal testing could detect maternal cancer
7/14/2015
Researchers have discovered that the findings of noninvasive prenatal screening could detect maternal cancer as well as chromosomal abnormalities in fetuses.
Molecule identified that facilitates spread of prostate cancer
7/14/2015
Drugs that inhibit the newly identified cancer molecule are already in early trials, raising the prospect of new avenues against prostate cancer.